Open Access Critical Evidence Review

Variability of first-pass hepatic insulin extraction measured directly and its association with insulin sensitivity and plasma insulin - A review of the evidence

In healthy dogs, lower initial hepatic insulin extraction was associated with higher fasting insulinemia and lower insulin sensitivity. The data show wide individual variability in clearance. Human studies support genetic and metabolic contributions, but do not prove that reduced clearance directly causes insulin resistance in people over time.

Cite this article
Mondini, M. (2026). Variability of first-pass hepatic insulin extraction measured directly and its association with insulin sensitivity and plasma insulin - A review of the evidence. Life Science Hub Journal. DOI: 10.5281/zenodo.24306174. https://lifesciencehub.info/en/variability-of-first-pass-hepatic-insulin-extraction-measured-directly-and-its-association-with
LIFE Science Hub - Journal of Science · 2026 / Nov

DOI 10.5281/zenodo.24306174

Article history
Dates
  • Published 16/11/2026
  • Updated 17/11/2026
Revisions
  1. v1.0 — 16/11/2026 Initial publication of the article.
  2. v1.1 — 17/11/2026 Editorial update of content, sources or references.

LIFE Science Hub keeps a record of every published version of the article to ensure editorial transparency. Future revisions will appear here.

Realistic liver in a laboratory setting, with transparent flows suggesting hepatic insulin extraction and metabolic variability.
A stylized yet realistic liver at the center of a scientific scene shows the varying first-pass insulin extraction. In the background, biological and laboratory elements suggest the link between clearance, fasting insulinemia, and insulin sensitivity.

ABSTRACT

The original study evaluated whether the proportion of insulin removed by the liver during its first pass through the portal circulation varied among healthy subjects and whether this variability was linked to fasting insulin and insulin sensitivity. In 12 healthy male dogs, first-pass hepatic extraction was measured using a direct experimental protocol based on insulin infusions into the portal vein and a peripheral vein. Extraction ranged from 22.4% to 77.2%; higher values were associated with greater insulin sensitivity and lower fasting insulin concentrations.

The research contributes to the passage from “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi, which states that insulin clearance is an individual physiological characteristic and that plasma insulin does not automatically reflect pancreatic secretion alone. Independent studies in humans indicate that clearance contributes significantly to fasting insulin levels, has a hereditary component, and can decrease during modest weight gain. However, the causal link between reduced clearance and subsequent insulin resistance requires further longitudinal studies.

Analyzed study

Variability of Directly Measured First-Pass Hepatic Insulin Extraction and Its Association With Insulin Sensitivity and Plasma Insulin

Asare-Bediako I, Paszkiewicz RL, Kim SP, Woolcott OO, Kolka CM, Burch MA, Kabir M, Bergman RN

Diabetes, 2018

DOI: 10.2337/db17-1520

PMID: 29752425

PMCID: PMC6054441

The research question was whether the liver, in addition to the pancreas, contributes to individual differences in blood insulin concentrations. The authors examined the hypothesis that greater first-pass hepatic extraction—that is, the amount of insulin removed by the liver before it reaches the rest of the body—is associated with better insulin sensitivity and lower fasting insulin levels.

The connection to the book's section concerns precisely the significant individual variability in insulin clearance. The publication directly demonstrates that, in healthy animals kept under controlled experimental conditions, hepatic insulin extraction can differ greatly from one subject to another and that this difference is associated with the amount of hormone present in peripheral circulation.

The study can document physiological associations in an animal model and use a direct measure of hepatic extraction. However, it cannot establish whether reduced extraction is the cause of insulin resistance, a consequence of it, or the result of common factors. Furthermore, it cannot automatically transfer the values measured in dogs to the human population.

Materials and methods of the original study

The study included 12 male mixed-breed dogs, approximately one year of age, with an average weight of 27.5 ± 1.0 kg. The animals were healthy, had liver function tests within the limits indicated by the authors, and were studied after overnight Fasting. Following a surgical procedure, a catheter was placed in the portal vein, the vessel that carries blood from the intestine and pancreas to the liver.

Each dog underwent three randomized experiments while awake, separated by at least three days. Insulin sensitivity was estimated using the hyperinsulinemic-euglycemic clamp, a technique in which insulin is infused while glucose is kept stable; the amount of glucose required to maintain this stability indicates how well the body responds to insulin.

First-pass hepatic extraction was calculated using two paired infusions. In one trial, insulin was infused into the portal vein, and in the other, into a peripheral vein. By comparing the insulin clearance rates in the two settings, the authors estimated the percentage removed by the liver during the first pass. They also measured the expression in the liver of INSR, the insulin receptor gene, and of CEACAM1 and IDE, proteins involved in cellular entry and insulin degradation, respectively.

Associations between variables were analyzed using Spearman's correlation, indicated as rs. This index describes whether two variables tend to increase or decrease together, but it does not demonstrate a cause-effect relationship. To describe the distribution of hepatic extraction, the authors added baseline data from six other dogs from a previous equivalent protocol.

Results

The main result was a wide variability in first-pass hepatic extraction. In the 12 dogs, the liver removed between 22.4% and 77.2% of the insulin it received through the portal vein; the mean value was 50.4 ± 19.1%. Including six dogs from a previous experiment, the mean in the 18 animals was 53.4%, with a standard deviation of 16.5 percentage points. In simple terms, healthy animals could eliminate very different amounts of insulin without showing overt glycemic alterations.

Higher hepatic extraction was associated with greater whole-body insulin sensitivity: rs = 0.74; P = 0.006. The P-value indicates that, according to the statistical criterion adopted by the authors, the observed association was unlikely to be due to chance alone. Conversely, higher extraction was associated with lower fasting insulin concentrations: rs = −0.64; P = 0.03. Insulin sensitivity was also inversely associated with fasting insulin: rs = −0.67; P = 0.02.

By excluding two dogs with particularly high fasting insulin levels from the analysis, the associations remained present and became stronger: hepatic extraction and insulin sensitivity rs = 0.82; P = 0.004; hepatic extraction and fasting insulin rs = −0.78; P = 0.008. This check reduces the risk that the entire result depends solely on two extreme observations, but it does not eliminate the limitation of the small sample size.

The relationship with insulin sensitivity was primarily linked to the response of peripheral tissues, particularly muscle and adipose tissue. Hepatic extraction was positively associated with peripheral sensitivity, rs = 0.80; P = 0.002, but not with the liver's sensitivity in suppressing glucose production, rs = 0.31; P = 0.33. Hepatic expression of INSR was positively associated with extraction, rs = 0.67; P = 0.02; however, CEACAM1 and IDE did not show statistically significant associations.

Interpretation

The physiological significance is that the concentration of insulin in the blood depends on two processes: how much insulin the pancreas releases and how much is cleared, primarily by the liver. If the liver removes a smaller portion of the hormone, a greater amount can reach the general circulation even without a proportional increase in pancreatic secretion.

The segment directly documented by the study is: individual differences in first-pass hepatic extraction → differences in fasting insulin concentrations and insulin sensitivity. The positive association with INSR is biologically compatible with the fact that the insulin receptor participates in the uptake of the hormone by liver cells. However, the measurement of gene expression does not prove that the receptor is the cause of the observed differences.

The research therefore supports the idea that clearance is not a secondary detail in the interpretation of insulinemia. However, it does not prove that low clearance causes insulin resistance. Since the study design is cross-sectional, both characteristics could depend on other physiological or metabolic determinants. Furthermore, extraction was measured in healthy dogs and not in people with obesity, prediabetes, or diabetes.

Independent supporting evidence

Initial confirmation in humans comes from an observational study conducted on 470 Hispanic-American adults without clinically manifest diabetes. Insulin metabolic clearance, measured during a hyperinsulinemic-euglycemic clamp, proved to be the strongest quantitative determinant of fasting insulin in a model that included insulin sensitivity, early secretion index, BMI, waist circumference, and glycemia. Overall, the variables considered explained 52% of the variability in fasting insulin levels. This result confirms the passage in the book stating that a high insulin value does not automatically equate to pancreatic hypersecretion [1].

The individual component hypothesized in the book is supported by a family analysis of Hispanic-American cohorts. Insulin clearance showed heritability estimates ranging from 0.35 to 0.73, depending on the cohort and the measurement method. In simple terms, a significant portion of the differences observed between people was compatible with genetic contributions. This does not identify specific responsible genes nor does it exclude environmental influence, but it makes it plausible that clearance is a partially heritable physiological trait [2].

A third study evaluated the role of modifiable metabolic factors by following 10 healthy men during an intentional increase of two BMI points, from 21.8 to 23.8 kg/m², over approximately four and a half months. After weight gain, basal insulin was higher; the authors' estimates indicated that reduced clearance contributed more to this change than increased secretion. After stimulation with a meal, oral glucose, or intravenous glucose, the increase in insulin was attributed to lower clearance, while C-peptide and estimated secretion did not change significantly. Although this was a very small sample consisting only of young men, the study supports the idea that clearance variability can also change in relation to early metabolic shifts [3].

Conflicting evidence

No directly conflicting evidence of sufficient relevance has been identified; this does not prove the absence of contradictory results.

However, there are significant interpretative limitations. The methods used in human studies often estimate whole-body insulin metabolic clearance, whereas the original study specifically measures first-pass hepatic extraction. Furthermore, clearance depends on the physiological context: fasting, meal, insulin concentration, body weight, and the degree of insulin resistance can all modify it. For this reason, the results do not justify considering a single fasting insulin measurement as proof of a single mechanism, nor do they allow for the deduction of a universal causal sequence.

Summary table of evidence

The table distinguishes the publication under review from independent evidence selected for its relevance to individual variability in insulin clearance and its relationship with insulinemia and metabolic status.

Reference Study type Population or model Main result Direction of evidence Strength of evidence
Original study Animal experimental, cross-sectional 12 healthy dogs; distribution extended to 18 with previous data First-pass hepatic extraction from 22.4% to 77.2%; higher extraction associated with greater insulin sensitivity and lower fasting insulin direct confirmation moderate
[1] Physiological observational 470 Hispanic-American adults without clinically manifest diabetes Metabolic clearance was the quantitatively strongest determinant of fasting insulin in the multivariate model direct confirmation moderate
[2] Family-based observational Hispanic-American family cohorts without diabetes Insulin clearance showed estimated heritability from 0.35 to 0.73 indirect confirmation moderate
[3] Non-randomized longitudinal intervention 10 healthy men subjected to modest weight gain Reduced clearance contributed to the increase in basal insulin and explained the increase in stimulated insulin biologically consistent evidence low

Confirmation of the evidence

Claim in the book

In section 3.4, "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi, it is stated that the wide dispersion of hepatic insulin extraction observed in healthy subjects suggests a strongly individual physiological characteristic, likely influenced by genetic, environmental, and metabolic factors.

Individual variability in hepatic clearance → different amount of insulin in peripheral blood → association with insulin sensitivity → possible influence of genetic and metabolic factors

The publication subject to the Evidence Review was used in the book to support the following passage: hepatic insulin extraction can vary widely even in conditions of apparent health, and this variability is associated with differences in fasting insulin levels and insulin sensitivity.

The correspondence between the analyzed publication and the paragraph is direct on a physiological level: in healthy dogs, greater first-pass hepatic extraction was associated with lower fasting insulin and higher insulin sensitivity. The study does not directly identify the genetic, environmental, or metabolic causes of this variability, but it demonstrates the central phenomenon that makes it necessary to distinguish between pancreatic secretion and clearance.

Independent evidence completes this narrative. In 470 Hispanic-American adults, metabolic clearance was the factor most strongly associated with fasting insulin, confirming that insulinemia is not an exclusive measure of secretion [1]. In Hispanic-American family cohorts, the hereditary component of clearance was significant, consistent with the possibility of individual genetic determinants [2]. In a small longitudinal study, a modest weight gain reduced clearance and increased circulating insulin, providing consistent evidence for the influence of environmental and metabolic factors [3].

In the context of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi, the literature therefore supports the need to interpret hyperinsulinemia by also considering the elimination of the hormone. However, based on this evidence alone, it remains unproven that reduced clearance is always the initial event or the cause of insulin resistance in humans.

Overall level of confirmation

MODERATE CONFIRMATION

The phenomenon of clearance variability and its relationship with insulinemia are supported by direct measurements in animal models and independent studies in humans. The genetic and metabolic components are consistent with observational data and a small longitudinal study, but the causal relationship and the specific hepatic fraction remain incompletely defined in humans.

Conclusions

The study analyzed documents a high degree of variability in first-pass hepatic insulin extraction in healthy dogs. Greater extraction was associated with lower fasting insulinemia and higher insulin sensitivity. Independent evidence in humans confirms that clearance contributes substantially to differences in circulating insulin and can be influenced by hereditary and metabolic factors.

The book's narrative is therefore moderately supported. The idea that plasma insulin does not exclusively measure pancreatic secretion is well-supported. Conversely, the hypothesis that reduced clearance regularly precedes and causes insulin resistance in people requires further validation.

Overall assessment

Individual variability in insulin clearance and its contribution to insulinemia are quite well supported. The physiological mechanism is consistent, and the book's narrative is confirmed by independent human studies. However, the demonstration that reduced clearance directly causes insulin resistance remains moderately supported and context-dependent.

References

[1] Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance

Goodarzi MO, Cui J, Chen YDI, Hsueh WA, Guo X, Rotter JI, 2011

American Journal of Physiology-Endocrinology and Metabolism

[2] Insulin Sensitivity and Insulin Clearance Are Heritable and Have Strong Genetic Correlation in Mexican Americans

Goodarzi MO, Langefeld CD, Xiang AH, Chen YI, Guo X, Hanley AJG, et al., 2014

Obesity

[3] Development of hyperinsulinemia and insulin resistance during the early stage of weight gain

Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V, 2008

American Journal of Physiology-Endocrinology and Metabolism

Editorial note

Artificial Intelligence was used solely as a tool to support editorial and documentary work. All content, interpretations, bibliographic citations and conclusions have been verified, reviewed and approved by the author, who assumes full scientific responsibility for them.

The manuscript was also subject to independent peer review prior to publication.

To ensure maximum transparency, the article's complete history — including the dates of submission, review, acceptance and publication, as well as information on the peer review process — is available on the dedicated Article History page.